Health Impact News reported late last year (December 2017) that vaccine manufacturer Sanofi Pasteur admitted that their vaccine for dengue (a deadly tropical disease spread mostly by mosquitoes) was defective.
In a press release from France, the pharmaceutical company admitted that the vaccine is harmful to those not previously infected with dengue, and could cause children not previously infected with dengue to contract a severe case of the disease.
More than 800,000 Filipino children have received at least one dose of Dengvaxia.
Former Philippine President Benigno Aquino III stated recently that he would not have approved a mass immunization program in 2015 using Dengvaxia had Sanofi Pasteur, the French pharmaceutical company that developed the dengue vaccine, made known then that the drug posed risks to the health of some people.
Reports of severe cases of Dengue and even some deaths have been related to the Dengvaxia vaccine, and the Philippine Department of Health (DOH) has setup "express lanes" at local hospitals to deal with illnesses and injuries due to the vaccine.
In the vaccine marketing trade publication FiercePharma, it is being reported that Sanofi is not going to let the "Dengvaxia mess" in the Philippines stop them from seeking FDA approval for the vaccine to be sold in the U.S.

In a story that is being mostly censored in the U.S. media, vaccine manufacturer Sanofi Pasteur has admitted that their vaccine for dengue (a deadly tropical disease spread mostly by mosquitoes) is defective.
In a press release from France, the pharmaceutical company admitted that the vaccine is harmful to those not previously infected with dengue, and could cause children not previously infected with dengue to contract a severe case of the disease.
The Philippines was the first country in Asia to approve the vaccine for individuals aged 9 and 45 years old in December 2015.
More than 730,000 Filipino children have received at least one dose of Dengvaxia, the first licensed vaccine for the virus, since the Philippine Department of Health launched the vaccination drive in schools last year.

Mainstream news media widely reported last month that a French teenager had filed a lawsuit against French pharmaceutical company, Sanofi Pasteur, and France's health regulators, over side-effects that were caused by the Gardasil HPV vaccine. Jean-Christophe Coubris Bordeaux is suffering from multiple sclerosis as a result of the Gardasil HPV vaccine.
This story is quite significant for two major reasons. First, you will never read a story like this happening in the United States, because you cannot sue a pharmaceutical company for damages as a result of vaccines in the United States. U.S. law, upheld by the U.S. Supreme Court in 2011, gives total immunity to pharmaceutical companies in the U.S. for any damages related to vaccine products.
Secondly, negative news regarding lawsuits or government action against vaccines in countries outside the U.S. are almost never reported in the U.S. media. How this one slipped through the cracks is not clear to me at this point. It could be that they believe they have an air-tight defense in this lawsuit, and that the overall media exposure for them will be positive on this. Or, it could be that Sanofi, a French company, does not have the same media lobbyists and influence that American and UK drug firms seem to have.
The news regarding Gardasil outside the U.S. is very negative, while the U.S. media has continued to propagate the notion that Gardasil is one of the safest vaccines on the market. Japan recently announced it had stopped recommending Gardasil vaccines and has begun a full investigation into the safety of the vaccine, amid numerous reports of severe injuries from side effects.
In addition to all the bad publicity Gardasil is receiving over severe side effects, including death, a study that was completely ignored by the U.S. media earlier this year, linked the HPV vaccine to premature menopause in teenage girls.
In another recent report that was completely ignored by the mainstream U.S. media, it was found that the Bill Gates funded group, PATH, which participated in HPV vaccine drug trials in India, violated the law resulting in fatalities of young girls during the drug trials. An investigation is ongoing in India.
Could we be looking at another Merck disaster similar to Vioxx, which reportedly killed more than 60,000 people before it was removed from the market?